Drug Side Effects
Search
ANORECTAL HUMAN PAPILLOMA VIRUS INFECTION
ANORECTAL HUMAN PAPILLOMA VIRUS INFECTION
was reported 30 times
ANORECTAL HUMAN PAPILLOMA VIRUS INFECTION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
SLAMF7-directed Immunostimulatory Antibody [EPC]
3
0.0006
1
CD38-directed Cytolytic Antibody [EPC]
3
0.0005
2
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
4
0.0002
3
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0001
4
Protease Inhibitor [EPC]
3
0.0001
5
Cytochrome P450 3A Inhibitor [EPC]
3
0.0000
6
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
4
0.0000
7
Provitamin D2 Compound [EPC]
1
0.0000
8
Interleukin-17A Antagonist [EPC]
1
0.0000
9
Proteasome Inhibitor [EPC]
3
0.0000
10
Nucleoside Analog Antiviral [EPC]
2
0.0000
11
Purine Antimetabolite [EPC]
2
0.0000
12
Alkylating Drug [EPC]
3
0.0000
13
Histamine-1 Receptor Antagonist [EPC]
1
0.0000
14
Anti-IgE [EPC]
1
0.0000
15
Central Nervous System Stimulant [EPC]
1
0.0000
16
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
17
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
18
Corticosteroid [EPC]
8
0.0000
19
Thalidomide Analog [EPC]
3
0.0000
20
Estrogen [EPC]
1
0.0000
21
Mood Stabilizer [EPC]
1
0.0000
22
Progestin [EPC]
1
0.0000
23
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
24
Atypical Antipsychotic [EPC]
1
0.0000
25
Proton Pump Inhibitor [EPC]
1
0.0000
26
Tumor Necrosis Factor Blocker [EPC]
1
0.0000